Cargando…

COPD exacerbations by disease severity in England

OBJECTIVES: Exacerbations of chronic obstructive pulmonary disease (COPD) are associated with accelerated disease progression and are important drivers of health care resource utilization. The study aimed to quantify the rates of COPD exacerbations in England and assess health care resource utilizat...

Descripción completa

Detalles Bibliográficos
Autores principales: Merinopoulou, Evie, Raluy-Callado, Mireia, Ramagopalan, Sreeram, MacLachlan, Sharon, Khalid, Javaria Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824283/
https://www.ncbi.nlm.nih.gov/pubmed/27099486
http://dx.doi.org/10.2147/COPD.S100250
_version_ 1782426064069328896
author Merinopoulou, Evie
Raluy-Callado, Mireia
Ramagopalan, Sreeram
MacLachlan, Sharon
Khalid, Javaria Mona
author_facet Merinopoulou, Evie
Raluy-Callado, Mireia
Ramagopalan, Sreeram
MacLachlan, Sharon
Khalid, Javaria Mona
author_sort Merinopoulou, Evie
collection PubMed
description OBJECTIVES: Exacerbations of chronic obstructive pulmonary disease (COPD) are associated with accelerated disease progression and are important drivers of health care resource utilization. The study aimed to quantify the rates of COPD exacerbations in England and assess health care resource utilization by severity categories according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. METHODS: Data from the Clinical Practice Research Datalink linked to Hospital Episode Statistics were used to identify patients with a COPD diagnosis aged ≥40 years. Those with complete spirometric, modified Medical Research Council Dyspnea Scale information, and exacerbation history 12 months prior to January 1, 2011 (index date) were classified into GOLD severity groups. Study outcomes over follow-up (up to December 31, 2013) were exacerbation rates and resource utilization (general practitioner visits, hospital admissions). RESULTS: From the 44,201 patients in the study cohort, 83.5% were classified into severity levels GOLD A: 33.8%, GOLD B: 21.0%, GOLD C: 18.1%, and GOLD D: 27.0%. Mean age at diagnosis was 66 years and 52.0% were male. Annual exacerbation rates per person-year increased with severity, from 0.83 (95% confidence interval [CI]: 0.81–0.85) for GOLD A to 2.51 (95% CI: 2.47–2.55) for GOLD D. General practitioner visit rates per person-year also increased with severity, from 4.82 (95% CI: 4.74–4.93) for GOLD A to 7.44 (95% CI: 7.31–7.61) for GOLD D. COPD-related hospitalization rates per person-year increased from less symptoms (GOLD A: 0.28, GOLD C: 0.39) to more symptoms (GOLD B: 0.52, GOLD D: 0.84). CONCLUSION: Patients in the most severe category (GOLD D) experienced nearly three times the number of exacerbations and COPD-related hospitalizations as those in the least severe category (GOLD A), in addition to increased general practitioner visits. Better patient management to stabilize the disease progression could allow for an improvement in exacerbation frequency and a reduction in health care resource utilization.
format Online
Article
Text
id pubmed-4824283
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-48242832016-04-20 COPD exacerbations by disease severity in England Merinopoulou, Evie Raluy-Callado, Mireia Ramagopalan, Sreeram MacLachlan, Sharon Khalid, Javaria Mona Int J Chron Obstruct Pulmon Dis Original Research OBJECTIVES: Exacerbations of chronic obstructive pulmonary disease (COPD) are associated with accelerated disease progression and are important drivers of health care resource utilization. The study aimed to quantify the rates of COPD exacerbations in England and assess health care resource utilization by severity categories according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. METHODS: Data from the Clinical Practice Research Datalink linked to Hospital Episode Statistics were used to identify patients with a COPD diagnosis aged ≥40 years. Those with complete spirometric, modified Medical Research Council Dyspnea Scale information, and exacerbation history 12 months prior to January 1, 2011 (index date) were classified into GOLD severity groups. Study outcomes over follow-up (up to December 31, 2013) were exacerbation rates and resource utilization (general practitioner visits, hospital admissions). RESULTS: From the 44,201 patients in the study cohort, 83.5% were classified into severity levels GOLD A: 33.8%, GOLD B: 21.0%, GOLD C: 18.1%, and GOLD D: 27.0%. Mean age at diagnosis was 66 years and 52.0% were male. Annual exacerbation rates per person-year increased with severity, from 0.83 (95% confidence interval [CI]: 0.81–0.85) for GOLD A to 2.51 (95% CI: 2.47–2.55) for GOLD D. General practitioner visit rates per person-year also increased with severity, from 4.82 (95% CI: 4.74–4.93) for GOLD A to 7.44 (95% CI: 7.31–7.61) for GOLD D. COPD-related hospitalization rates per person-year increased from less symptoms (GOLD A: 0.28, GOLD C: 0.39) to more symptoms (GOLD B: 0.52, GOLD D: 0.84). CONCLUSION: Patients in the most severe category (GOLD D) experienced nearly three times the number of exacerbations and COPD-related hospitalizations as those in the least severe category (GOLD A), in addition to increased general practitioner visits. Better patient management to stabilize the disease progression could allow for an improvement in exacerbation frequency and a reduction in health care resource utilization. Dove Medical Press 2016-04-01 /pmc/articles/PMC4824283/ /pubmed/27099486 http://dx.doi.org/10.2147/COPD.S100250 Text en © 2016 Merinopoulou et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Merinopoulou, Evie
Raluy-Callado, Mireia
Ramagopalan, Sreeram
MacLachlan, Sharon
Khalid, Javaria Mona
COPD exacerbations by disease severity in England
title COPD exacerbations by disease severity in England
title_full COPD exacerbations by disease severity in England
title_fullStr COPD exacerbations by disease severity in England
title_full_unstemmed COPD exacerbations by disease severity in England
title_short COPD exacerbations by disease severity in England
title_sort copd exacerbations by disease severity in england
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824283/
https://www.ncbi.nlm.nih.gov/pubmed/27099486
http://dx.doi.org/10.2147/COPD.S100250
work_keys_str_mv AT merinopoulouevie copdexacerbationsbydiseaseseverityinengland
AT raluycalladomireia copdexacerbationsbydiseaseseverityinengland
AT ramagopalansreeram copdexacerbationsbydiseaseseverityinengland
AT maclachlansharon copdexacerbationsbydiseaseseverityinengland
AT khalidjavariamona copdexacerbationsbydiseaseseverityinengland